# DPP4 Inhibition & Beta Cell Function

> **NCT02683187** · PHASE1 · COMPLETED · sponsor: **David D'Alessio, M.D.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Active Comparator: Sitagliptin
- **DRUG:** Placebo Comparator - No Sitagliptin

## Key facts

- **NCT ID:** NCT02683187
- **Lead sponsor:** David D'Alessio, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-03-16
- **Final completion:** 2018-03-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02683187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02683187, "DPP4 Inhibition & Beta Cell Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02683187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*